UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Psychosocial Care for Injured Children: Worldwide Survey among Hospital Emergency Department Staff

The Journal of pediatrics, 2016-03, Vol.170, p.227-233.e6

2016

Volltextzugriff (PDF)

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Maturitas, 2014-03, Vol.77 (3), p.274-281

2014

Volltextzugriff (PDF)

Tolterodine Extended Release Is Efficacious in Continent and Incontinent Subjects with Overactive Bladder

Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.488-493

2008

Volltextzugriff (PDF)

Albuminuria in chronic heart failure: prevalence and prognostic importance

The Lancet (British edition), 2009-08, Vol.374 (9689), p.543-550

2009

Volltextzugriff (PDF)

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

The American heart journal, 2011-11, Vol.162 (5), p.900-906

2011

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.772-776

2003

Volltextzugriff (PDF)

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

The Lancet (British edition), 2009-09, Vol.374 (9694), p.989-997

2009

Volltextzugriff (PDF)

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

The Lancet (British edition), 2005-12, Vol.366 (9502), p.2005-2011

2005

Volltextzugriff (PDF)

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Journal of the American College of Cardiology, 2007-07, Vol.50 (1), p.40-47

2007

Volltextzugriff (PDF)

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1785-1795

2012

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.777-781

2003

Volltextzugriff (PDF)

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1997-2004

2006

Volltextzugriff (PDF)

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-05, Vol.13 (5), p.461-471

2014

Volltextzugriff (PDF)

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

Alzheimer's & dementia, 2020-03, Vol.16 (3), p.541-551

2020

Volltextzugriff (PDF)

Assessing surgical site infection risk factors using electronic medical records and text mining

American journal of infection control, 2014-03, Vol.42 (3), p.333-336

2014

Volltextzugriff (PDF)

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

The American heart journal, 2006-07, Vol.152 (1), p.86-92

2006

Volltextzugriff (PDF)

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

Journal of the American College of Cardiology, 2007-11, Vol.50 (20), p.1959-1966

2007

Volltextzugriff (PDF)

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Journal of the American College of Cardiology, 2011-05, Vol.57 (19), p.1908-1916

2011

Volltextzugriff (PDF)

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.2000-2007

2008

Volltextzugriff (PDF)

Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2016-12, Vol.123 (12), p.2554-2570

2016

Volltextzugriff (PDF)

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Biological psychiatry (1969), 2016-01, Vol.79 (2), p.136-148

2016

Volltextzugriff (PDF)

Frequency of Aspirin Resistance in a Community Hospital

The American journal of cardiology, 2006-09, Vol.98 (5), p.577-579

2006

Volltextzugriff (PDF)

Diffusion Tensor Imaging Detects Rarefaction of Optic Radiation in Glaucoma Patients

Academic radiology, 2011-06, Vol.18 (6), p.764-769

2011

Volltextzugriff (PDF)

Glaucoma classification based on visual pathway analysis using diffusion tensor imaging

Magnetic resonance imaging, 2013-09, Vol.31 (7), p.1081-1091

2013

Volltextzugriff (PDF)

Evidence of isometric function of the flexor hallucis longus muscle in normal gait

Journal of biomechanics, 2008-01, Vol.41 (9), p.1919-1928

2008

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Psychosocial Care for Injured Children: Worldwide Survey among Hospital Emergency Department Staff

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Tolterodine Extended Release Is Efficacious in Continent and Incontinent Subjects with Overactive Bladder

Albuminuria in chronic heart failure: prevalence and prognostic importance

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

Assessing surgical site infection risk factors using electronic medical records and text mining

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Frequency of Aspirin Resistance in a Community Hospital

Diffusion Tensor Imaging Detects Rarefaction of Optic Radiation in Glaucoma Patients

Glaucoma classification based on visual pathway analysis using diffusion tensor imaging

Evidence of isometric function of the flexor hallucis longus muscle in normal gait

Aktive Filter

Suchergebnisse filtern